Acute lymphoblastic leukaemia trials in Greece
8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 4Taking peopleAsciminib Roll-over Study
- Where
- Athens, Thessaloniki
- Age
- 7 years to 100 years
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - Phase 1/2Taking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Athens
- Age
- 6 months to 25 years
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - Phase 2/3Taking peopleA Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
- Where
- Athens, Chaïdári, Ioannina
- Age
- 12 years and over
- People
- 340 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07570173 · EU 2025-522267-15-00 - Phase 3Taking peopleInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
- Where
- Athens, Heraklion, Marousi, Thessaloniki
- Age
- 1 day to 1 year
- People
- 160 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00 - Phase 2Taking peopleA Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
- Where
- Athens
- Age
- 1 year to 17 years
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05748171 · EU 2023-509810-13-00 - Phase 2/3Taking peopleAllogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
- Where
- Athens
- Age
- 1 month to 18 years
- People
- 1,800 worldwide
- Run by
- St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00 - Phase 4Taking peopleALLIC 2022 international clinical investigation for advanced management of childhood acute lymphoblastic leukemia
- Where
- Athens, Heraklion, Marousi, Thessaloniki
- Age
- Up to 17 years
- People
- 775 worldwide
- Run by
- Semmelweis University
See details and how to join2024-513824-41-00 · EU 2024-513824-41-00 - Phase 3Taking peopleA Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
- Where
- Athens, Chaïdári, Patras
- Age
- 18 years and over
- People
- 350 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06051409 · EU 2024-511496-14-00